Ozempic is FDA-approved to reduce the risk of major adverse cardiovascular events (including heart attack, stroke, and cardiovascular death) in individuals with type 2 diabetes and heart disease
doi:10.1056/NEJMoa2032183 Youmshajekian L, Tedeschi V
Long-term management and monitoring are vital for patients on semaglutide
Its a single-hormone agent that mimics glucagon-like peptide-1, or GLP-1, according to Chika Anekwe, obesity medicine clinical director at Massachusetts General Hospitals weight center
Points to Keep in Mind This stack is highly experimental and requires licensed medical supervision
Oxidative Medicine and Cellular Longevity, 2012 , 324832